March 11, 2020
REDWOOD CITY, Calif. , March 11, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read MoreMarch 04, 2020
REDWOOD CITY, Calif. , March 04, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read MoreJanuary 06, 2020
Company Continues to Expect Top-line Data in First Half of 2020 REDWOOD CITY, Calif. , Jan. 06, 2020 (GLOBE ...
Read More
Developing novel therapeutics for the treatment of rare diseases.